![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 9, 5349-5357, February 27, 1998
From the Department of Molecular Biology and Pharmacology,
Washington University Medical School, St. Louis, Missouri 63110
Fibroblast growth factor receptor 3 (FGFR3) has a
complex spatial and temporal pattern of expression and is essential for the normal development of a diverse set of tissues. Recently, mutations
have been identified in FGFR3 that result in constitutive tyrosine
kinase activity and cause a number of different human skeletal
disorders. To examine the regulatory mechanisms governing FGFR3
expression, the promoter for the FGFR3 gene was identified and
characterized. It resides in a CpG island, which encompasses the 5' end
of the FGFR3 gene and lacks classical cis-regulatory motifs. As little as 100 base pairs of sequence 5' to the initiation site can confer a 20-40-fold increase in transcriptional activity upon
a promoter-less vector. The transcriptional activity of these cis-regulatory sequences is further stimulated by elements
found within the first intron. Mapping of the enhancer activity found within intron I identified two purine-rich sequence motifs between +340
and +395. Electrophoretic mobility shift assays demonstrated that
sequences within this region bind members of the Sp1 family of
transcription factors. In a background lacking Sp1-like activity, we
demonstrate that Sp1 can enhance transcription of the minimal promoter
(which contains five classical Sp1 sites), whereas both Sp1 and Sp3 can
enhance transcription through the elements found in intron I. Although
these transcription factors are ubiquitously expressed, we demonstrate
that the sequences between
Regulation of the Fibroblast Growth Factor Receptor 3 Promoter
and Intron I Enhancer by Sp1 Family Transcription Factors
220 and +609 of the FGFR3 gene are
sufficient to promote the tissue-specific expression of a reporter gene
in transgenic mice.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. W. Shin, M. Min, F. Larrieu-Lahargue, X. Canron, R. Kunstfeld, L. Nguyen, J. E. Henderson, A. Bikfalvi, M. Detmar, and Y.-K. Hong Prox1 Promotes Lineage-specific Expression of Fibroblast Growth Factor (FGF) Receptor-3 in Lymphatic Endothelium: A Role for FGF Signaling in Lymphangiogenesis Mol. Biol. Cell, February 1, 2006; 17(2): 576 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Reinhold, D. G. McEwen, and M. C. Naski Fibroblast Growth Factor Receptor 3 Gene: Regulation by Serum Response Factor Mol. Endocrinol., January 1, 2004; 18(1): 241 - 251. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, S. L. Asa, R. J. Weigel, and S. Ezzat Pituitary Tumor AP-2{alpha} Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4 J. Biol. Chem., May 23, 2003; 278(22): 19597 - 19602. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Rao, S. Maiti, H. N. Ananthaswamy, and M. F. Wilkinson A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell Types J. Biol. Chem., July 12, 2002; 277(29): 26036 - 26045. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, S. L. Asa, and S. Ezzat Fibroblast Growth Factor Receptor 4 Is a Target for the Zinc-Finger Transcription Factor Ikaros in the Pituitary Mol. Endocrinol., May 1, 2002; 16(5): 1069 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Parakati and J. X. DiMario Sp1- and Sp3-mediated Transcriptional Regulation of the Fibroblast Growth Factor Receptor 1 Gene in Chicken Skeletal Muscle Cells J. Biol. Chem., March 8, 2002; 277(11): 9278 - 9285. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Hayashi, A Ishisaki, M Suzuki, and T Imamura BMP-2 augments FGF-induced differentiation of PC12 cells through upregulation of FGF receptor-1 expression J. Cell Sci., January 4, 2001; 114(7): 1387 - 1395. [Abstract] [PDF] |
||||
![]() |
K. Yu, A. B. Herr, G. Waksman, and D. M. Ornitz Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome PNAS, December 19, 2000; 97(26): 14536 - 14541. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Vajo, C. A. Francomano, and D. J. Wilkin The Molecular and Genetic Basis of Fibroblast Growth Factor Receptor 3 Disorders: The Achondroplasia Family of Skeletal Dysplasias, Muenke Craniosynostosis, and Crouzon Syndrome with Acanthosis Nigricans Endocr. Rev., February 1, 2000; 21(1): 23 - 39. [Abstract] [Full Text] |
||||
![]() |
O. Segev, I. Chumakov, Z. Nevo, D. Givol, L. Madar-Shapiro, Y. Sheinin, M. Weinreb, and A. Yayon Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice Hum. Mol. Genet., January 22, 2000; 9(2): 249 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. SUSINI, G. VAN HAASTEREN, S. LI, M. PRENTKI, and W. SCHLEGEL Essentiality of intron control in the induction of c-fos by glucose and glucoincretin peptides in INS-1 {beta}-cells FASEB J, January 1, 2000; 14(1): 128 - 136. [Abstract] [Full Text] |
||||
![]() |
D. G. McEwen, R. P. Green, M. C. Naski, D. A. Towler, and D. M. Ornitz Fibroblast Growth Factor Receptor 3 Gene Transcription Is Suppressed by Cyclic Adenosine 3',5'-Monophosphate. IDENTIFICATION OF A CHONDROCYTIC REGULATORY ELEMENT J. Biol. Chem., October 22, 1999; 274(43): 30934 - 30942. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gemel, C. Jacobsen, and C. A. MacArthur Fibroblast Growth Factor-8 Expression Is Regulated by Intronic Engrailed and Pbx1-binding Sites J. Biol. Chem., February 26, 1999; 274(9): 6020 - 6026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |